Molina projects fivefold profit by 2029

Health insurance is a cost-control business first and a growth story second. That is the frame for Molina Healthcare’s new 2029 plan. On May 8, the Medicaid-focused insurer told investors it sees adjusted earnings per share rising to roughly $25 to $30 by 2029, versus a 2026 outlook of at least $5. The pitch is simple on paper — hold medical costs in line, let rates catch up, and expand margins. The catch is that almost every part of the upside runs through that same bottleneck. ### What did Molina actually announce? Molina used its investor day to publish a three-year outlook built around 2029 premium revenue and adjusted EPS targets. The headline number was adjusted EPS of about $25 to $30 by 2029. That is why people are calling it a fivefold profit plan — the company’s current 2026 guidance is still only at least $5 per share. (investors.molinahealthcare.com) ### Why is the jump so big? The company is not saying revenue alone will do it. The bigger driver is margin repair. Morningstar’s read of the investor-day targets says Molina is aiming to move adjusted pretax margin from under 1% in 2026 to about 2.5% by 2029. In other words, this is less “we’ll sell way more insurance” and more “we’ll earn a lot more on each premium dollar.” (investors.molinahealthcare.com) ### Why do medical costs matter so much? Because medical costs are the main line item that can wreck an insurer’s year. Molina’s first-quarter 2026 medical care ratio was 91.1%, up from 89.2% a year earlier. When that ratio rises, more of every premium dollar gets spent on care and less is left over as profit. A two-point move sounds small, but at Molina’s scale it hits hard. (morningstar.com) ### Didn’t Molina just have a rough reset? Yes — and that is why investors are skeptical. In February, Molina shocked the market with a 2026 profit outlook far below Wall Street expectations after medical costs climbed across its government-backed plans. Reuters noted the stock plunged more than 28% on that earlier reset. So this new 2029 target lands only a few months after management had to admit the near-term picture was much worse than expected. (sec.gov) ### What improved since then? The first quarter was better, but not clean. Molina posted adjusted EPS of $2.35 and said medical cost trend was modestly favorable to expectations, so it reaffirmed full-year 2026 guidance instead of cutting again. But revenue fell, membership slipped, and GAAP profit dropped sharply from a year earlier. That tells you the business stabilized somewhat, not that the problem disappeared. (uk.marketscreener.com) ### Why are analysts uneasy? Because the logic of the plan is narrow. Reuters framed the target as contingent on keeping medical costs in check, and the stock still fell about 3% on the day. Healthcare Dive had already flagged a related risk in April — Medicaid membership losses can leave behind a sicker pool, which pushes spending up even if total enrollment falls. Basically, Molina needs cost discipline and a favorable mix shift at the same time. (sec.gov) ### Does the business mix make this harder? A bit, yes. Molina is heavily exposed to Medicaid and other government programs, where pricing and reimbursement are less flexible than in commercial insurance. That means if care gets more expensive faster than states or regulators adjust rates, margins compress quickly. Molina is also pruning weaker Medicare Advantage products, which may help later but hurts reported results now. (msn.com) ### Bottom line Molina’s message is that 2026 is the trough and 2029 is the payoff. That could happen. But the company is asking investors to believe that the same medical-cost pressure that just blew up its near-term earnings will stay contained long enough to power a dramatic rebound. (investors.molinahealthcare.com) (healthcaredive.com)